136 related articles for article (PubMed ID: 28769289)
1. HYPERLIPIDEMIA IN A CHILD: A Case Report.
Vidyashankar C
Med J Armed Forces India; 1995 Jul; 51(3):209-210. PubMed ID: 28769289
[No Abstract] [Full Text] [Related]
2. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.
Goldstein JL; Schrott HG; Hazzard WR; Bierman EL; Motulsky AG
J Clin Invest; 1973 Jul; 52(7):1544-68. PubMed ID: 4718953
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia.
Molcányiová A; Stancáková A; Javorský M; Tkác I
Pharmacol Res; 2006 Sep; 54(3):203-7. PubMed ID: 16737822
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.
Derosa G; D'Angelo A; Franzetti IG; Ragonesi PD; Gadaleta G; Scalise F; Ciccarelli L; Piccinni MN; Cicero AF
J Clin Pharm Ther; 2009 Jun; 34(3):267-76. PubMed ID: 19650249
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia.
Vega GL; Toto RD; Grundy SM
Kidney Int; 1995 Feb; 47(2):579-86. PubMed ID: 7723244
[TBL] [Abstract][Full Text] [Related]
6. Pediatric cholesterol screening: missed opportunities.
Liacouras CA; Shamir R
Isr J Med Sci; 1997 Oct; 33(10):659-62. PubMed ID: 9397139
[TBL] [Abstract][Full Text] [Related]
7. Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis).
Paramsothy P; Knopp RH; Bertoni AG; Blumenthal RS; Wasserman BA; Tsai MY; Rue T; Wong ND; Heckbert SR
J Am Coll Cardiol; 2010 Sep; 56(13):1034-41. PubMed ID: 20846602
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and expression of familial combined hyperlipidemia in childhood.
Cortner JA; Coates PM; Gallagher PR
J Pediatr; 1990 Apr; 116(4):514-9. PubMed ID: 2319396
[TBL] [Abstract][Full Text] [Related]
9. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 2: Hypercholesterolemia.
Choluj B; Votruba T
Acta Univ Carol Med (Praha); 1991; 37(3-4):106-15. PubMed ID: 1845465
[TBL] [Abstract][Full Text] [Related]
10. Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia.
Tatò F; Vega GL; Tall AR; Grundy SM
Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):112-20. PubMed ID: 7749806
[TBL] [Abstract][Full Text] [Related]
11. [The effect of hyperlipidemia on metabolism, distribution and secretion of lidocaine in patients with primary hyperlipidemia].
Rózański J
Ann Acad Med Stetin; 2000; 46():177-87. PubMed ID: 11712303
[TBL] [Abstract][Full Text] [Related]
12. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs.
Stacy TA; Egger A
J Manag Care Pharm; 2006; 12(9):745-51. PubMed ID: 17249907
[TBL] [Abstract][Full Text] [Related]
13. Hypercholesterolemia as a risk factor for deep-vein thrombosis.
Kawasaki T; Kambayashi J; Ariyoshi H; Sakon M; Suehisa E; Monden M
Thromb Res; 1997 Oct; 88(1):67-73. PubMed ID: 9336875
[TBL] [Abstract][Full Text] [Related]
14. Family history fails to identify many children with severe hypercholesterolemia.
Starc TJ; Belamarich PF; Shea S; Dobrin-Seckler BE; Dell RB; Gersony WM; Deckelbaum RJ
Am J Dis Child; 1991 Jan; 145(1):61-4. PubMed ID: 1985431
[TBL] [Abstract][Full Text] [Related]
15. Severe hyperlipidemia due to multiple factors in a child with nephrotic syndrome.
Ongkingco JR; Mann WA; Ruley EJ; Gregg RE
Child Nephrol Urol; 1991; 11(2):107-10. PubMed ID: 1756519
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia.
Li ZZ; Huang Q; Yang XL; Zeng J; Wang QH; Tang HM; Yu ZQ; Song YQ; Liu Y
Dis Markers; 2022; 2022():2008556. PubMed ID: 35493299
[TBL] [Abstract][Full Text] [Related]
17. A case of autosomal recessive hypercholesterolemia responsive to proprotein convertase subtilisin/kexin 9 inhibition.
Fahy EF; McCarthy E; Steinhagen-Thiessen E; Vaughan CJ
J Clin Lipidol; 2017; 11(1):287-288. PubMed ID: 28391897
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E phenotypes and hyperlipidemia.
Utermann G; Kindermann I; Kaffarnik H; Steinmetz A
Hum Genet; 1984; 65(3):232-6. PubMed ID: 6698547
[TBL] [Abstract][Full Text] [Related]
19. Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome.
Toto RD; Grundy SM; Vega GL
Am J Nephrol; 2000; 20(1):12-7. PubMed ID: 10644862
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of ML-236B in primary hypercholesterolemia.
Yamamoto A; Sudo H; Endo A
Atherosclerosis; 1980 Mar; 35(3):259-66. PubMed ID: 7362699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
